Christopher Van Dyck, MD
1 Church St 8th Floor, New Haven, CT 06510
5.0
(1 reviews)
About the Practice
He was the lead author on the study that established lecanemab as the first disease-modifying treatment for Alzheimer’s disease. Predictive and monitoring value of blood‐based biomarkers for apathy treatment in Alzheimer’s disease.
Category
ADHD
Aging/Elderly
Childhood Trauma
Depression
Gender Identity
Grief
LGBTQ+
Sexual Abuse
Practice Context in IntroTherapy
- • IntroTherapy lists 366 mental health practices in New Haven. Christopher Van Dyck, MD is one of them.
- • 5,921 practices statewide in Connecticut are tracked in our directory.
- • 692 practices in Connecticut list ADHD as a focus area.
- • 45 practices in New Haven accept EmblemHealth.
- • Typical psychiatrist compensation in Connecticut: $214,000 – $375,000 (median $274,000). Source: BLS OEWS, state cost-of-labor adjusted.
Data compiled from U.S. state licensing boards, NPI public registry, and verified practice listings. Mental health is a YMYL topic — we prioritize licensed, verified providers only. Methodology & sources · Updated July 2026.
Insurance Accepted
EmblemHealth
Reviews & Ratings
5.0
1 total reviews
Contact Provider
View on MapsIs this your practice?
Claim your free profile today
Update your info, respond to reviews, and connect with new clients.
Claim This ProfileRequest Appointment
Christopher Van Dyck, MD